Table 2.
Clinical presentation, treatment and outcome of the children with neurological complications of 2009 H1N1 virus infection at Evelina Children’s Hospital
Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | |
---|---|---|---|---|---|
Age at presentation | 2 years 10 months | 4 years 6 months | 10 years 5 months | 5 years 5 months | 10 months |
Sex | Male | Female | Male | Female | Male |
Race | African Carribean | Caucasian | Asian | Caucasian | Caucasian |
Past medical history | Febrile convulsions mild speech delay | None | None | Asthma | Down’s syndrome |
Duration to neurological symptoms | 3 days | 2 days | 7 days | 2 days | 7 days |
Seizures | + | + | + | + | − |
Encephalopathy | − | + | + | + | + |
Encephalitis | − | + | + | − | − |
Fever, °C | 38 | 38.9 | 39 | 40 | 40 |
Antiviral therapy | Oseltamivir | Oseltamivir, changed to zanamavir | Oseltamivir | Oseltamivir | Oseltamivir |
IVIG 1 course = 1 g/kg/day for 2 days | None | 1 course | 3 courses, 1 month apart | 1 course | None |
Outcome | Level 2 | Level 1 | Level 3 | Level 3 | Level 1 |
IVIG intravenous immunoglobulin, + present, − absent, outcome level 1 normal resolution, level 2 mild sequelae, level 3 severe sequelae requiring personal help for daily activities, level 4 death